Regulatory News
Wednesday, August 31, 2016
BRIEF-Allergan and Adamas enter settlement with Amneal Pharmaceuticals
* Allergan and Adamas announce settlement with Amneal
related to namzaric patent litigation
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment